Clinical Trials Directory

Trials / Completed

CompletedNCT00176969

Response of Topical Capsaicin in Alopecia Areata

Perifollicular Nerves in Alopecia Areata: Response to Topical Capsaicin

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (planned)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

It has been postulated that Alopecia Areata (AA) is, at least in part, a neurologically mediated disease. Research supporting this theory includes the finding that nerves surrounding the hair follicles are collapsed. We want to take this research a step further and show that not only are these perifollicular nerves collapsed, but that their function is also impaired.

Detailed description

To assess the function of perifollicular scalp nerves in AA we will look at the response of these nerves to the topical medication capsaicin. Under normal circumstances topical capsaicin is known to target nerves in the peripheral nervous system causing short-term release of the neuropeptide Substance P (SP) as well as long-term transient depletion of SP. We expect the AA patients will respond abnormally to topical capsaicin treatment.

Conditions

Interventions

TypeNameDescription
DRUGCapsaicin

Timeline

Start date
1997-08-01
Completion
2000-06-01
First posted
2005-09-15
Last updated
2014-06-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00176969. Inclusion in this directory is not an endorsement.

Response of Topical Capsaicin in Alopecia Areata (NCT00176969) · Clinical Trials Directory